1-20 of 1793 Search Results for

agonist

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Book Chapter
Series: Endocrine Development
Volume: 29
Published: 22 December 2015
10.1159/000438893
EISBN: 978-3-318-02789-1
... to consider combination of growth hormone and GnRH agonist therapy [ 12 ]. Period of Treatment Doses and Formulations All available GnRH analogs are effective despite their different routes of administration, dosing and duration of action [ 2 , 6 , 13 , 14 ]. Routes and frequency of administration...
Book Chapter
Series: Endocrine Development
Volume: 30
Published: 10 December 2015
10.1159/000439323
EISBN: 978-3-318-05637-2
... among adults. Among these, glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment appears to have reasonable weight loss efficacy along with other beneficial pleiotropic effects. Although larger trials will be required to confirm the results, two small pediatric clinical trials have suggested...
Book Chapter
Series: Endocrine Development
Volume: 30
Published: 10 December 2015
10.1159/000439337
EISBN: 978-3-318-05637-2
.... This hypothalamic-pituitary-gonadal (HPG) axis has, therefore, been the target for the development of numerous drugs which regulate it at various points. These include sex steroid agonists and antagonists, inhibitors of sex steroid biosynthesis, and GnRH agonists and antagonists, which have found extensive...
Book Chapter
Series: Progress in Respiratory Research
Volume: 39
Published: 31 August 2010
10.1159/000320795
EISBN: 978-3-8055-9567-4
...Indacaterol: A new once-daily long-acting β2-adrenoceptor agonist (LABA) Introduction An important step in simplifying the management of chronic airway diseases like chronic obstructive pulmonary disease (COPD), and improving the adherence with prescribed therapy is the attempt...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 35
Published: 21 June 2006
10.1159/000094312
EISBN: 978-3-318-01379-5
... Abstract Dopamine agonists (DA) are the treatment of choice for both micro- and macroadenomas.However, the only limitation of this treatment is the low rate of cure, as well as thelong-term therapy usually seen in most patients. In our data, 16% of patients with prolactinomasremained...
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Series: Contributions to Gynecology and Obstetrics
Volume: 16
Published: 24 November 1987
10.1159/000414894
EISBN: 978-3-318-03239-0
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Book Chapter
Series: Progress in Respiratory Research
Volume: 31
Published: 08 March 2001
10.1159/000062133
EISBN: 978-3-318-00424-3
Book Chapter
Book Chapter
Series: Progress in Respiratory Research
Volume: 31
Published: 08 March 2001
10.1159/000062130
EISBN: 978-3-318-00424-3